acquired
Stage
4
Investors
About
Noctrix Health develops wearable therapeutics for chronic neurological disorders, with its lead product Nidra offering a non-invasive, FDA-authorized therapy for moderate-to-severe Restless Legs Syndrome (RLS).
Explore Noctrix Health's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.